Atherosclerosis:地中海饮食减少动脉硬化性卒中的发生

2015-10-11 phylis 译 MedSci原创

背景:地中海饮食似乎与心血管疾病,癌症,阿尔兹海默病,帕金森病以及由于心血管疾病死亡风险降低相关。没有研究证实急性缺血性卒中患者进行地中海饮食与卒中亚型和其严重性程度的关系。目的:进行回顾性的研究评估地中海饮食与TOAST亚型和卒中严重程度的关系。方法:根据TOAST标准对急性缺血性卒中进行分类。所有进入病区的急性缺血性卒中患者完成适合西西里人群的137项食物频率调查问卷。这是一项评估传统的地中海

背景:地中海饮食似乎与心血管疾病、癌症、阿尔兹海默病、帕金森病以及由于心血管疾病的死亡风险降低相关。没有研究证实急性缺血性卒中患者进行地中海饮食与卒中亚型和其严重性程度的关系。

目的:进行回顾性的研究评估地中海饮食与TOAST亚型和卒中严重程度的关系。

方法:根据TOAST标准对急性缺血性卒中进行分类。所有进入病区的急性缺血性卒中患者完成适合西西里人群的137项食物频率调查问卷。这是一项评估传统的地中海饮食程度的量表(分数:0-9)。

结果:198名急性缺血性患者,100名无卒中的对照组受试者。与对照组相比,卒中患者平均地中海饮食平均分数较低。研究人员观察到地中海饮食分数与SSS分数呈正相关,然而,地中海饮食与NHISS和Rankin分数呈负相关。与其他类型卒中相比,动脉粥样硬化卒中(LAAS)类型患者平均地中海饮食分数较低。非条件多元logistic回归分析显示地中海饮食分数与LAAS亚型和腔隙性梗死类型呈负相关,也与LAAS和心肺梗死类型呈负相关。

结论:较少进行地中海饮食的患者更可能发生动脉粥样硬化卒中,入院缺血性卒中更严重,并且出院Rankin分数较高。

原文出处:

Tuttolomondo A, Casuccio A, Buttà C.et al. Mediterranean Diet in patients with acute ischemic stroke: Relationships between Mediterranean Diet score, diagnostic subtype, and stroke severity index.Atherosclerosis. 2015 Sep 11.


版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (4)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1947302, encodeId=dc64194e3027c, content=<a href='/topic/show?id=d6bc160453b' target=_blank style='color:#2F92EE;'>#Sclerosis#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=16045, encryptionId=d6bc160453b, topicName=Sclerosis)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=33b92500139, createdName=12498b37m72暂无昵称, createdTime=Thu Jun 09 05:33:00 CST 2016, time=2016-06-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1364062, encodeId=49391364062f5, content=<a href='/topic/show?id=7c5615628ad' target=_blank style='color:#2F92EE;'>#ROS#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=15628, encryptionId=7c5615628ad, topicName=ROS)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=acc3210, createdName=lsndxfj, createdTime=Tue Oct 13 06:33:00 CST 2015, time=2015-10-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1496271, encodeId=aa1f14962e148, content=<a href='/topic/show?id=43b6e358710' target=_blank style='color:#2F92EE;'>#硬化性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73587, encryptionId=43b6e358710, topicName=硬化性)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d8119265602, createdName=Smile2683, createdTime=Tue Oct 13 06:33:00 CST 2015, time=2015-10-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1575434, encodeId=479015e5434fa, content=<a href='/topic/show?id=cd9941326bc' target=_blank style='color:#2F92EE;'>#地中海#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=41326, encryptionId=cd9941326bc, topicName=地中海)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=303116130321, createdName=wgx311, createdTime=Tue Oct 13 06:33:00 CST 2015, time=2015-10-13, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1947302, encodeId=dc64194e3027c, content=<a href='/topic/show?id=d6bc160453b' target=_blank style='color:#2F92EE;'>#Sclerosis#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=16045, encryptionId=d6bc160453b, topicName=Sclerosis)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=33b92500139, createdName=12498b37m72暂无昵称, createdTime=Thu Jun 09 05:33:00 CST 2016, time=2016-06-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1364062, encodeId=49391364062f5, content=<a href='/topic/show?id=7c5615628ad' target=_blank style='color:#2F92EE;'>#ROS#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=15628, encryptionId=7c5615628ad, topicName=ROS)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=acc3210, createdName=lsndxfj, createdTime=Tue Oct 13 06:33:00 CST 2015, time=2015-10-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1496271, encodeId=aa1f14962e148, content=<a href='/topic/show?id=43b6e358710' target=_blank style='color:#2F92EE;'>#硬化性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73587, encryptionId=43b6e358710, topicName=硬化性)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d8119265602, createdName=Smile2683, createdTime=Tue Oct 13 06:33:00 CST 2015, time=2015-10-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1575434, encodeId=479015e5434fa, content=<a href='/topic/show?id=cd9941326bc' target=_blank style='color:#2F92EE;'>#地中海#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=41326, encryptionId=cd9941326bc, topicName=地中海)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=303116130321, createdName=wgx311, createdTime=Tue Oct 13 06:33:00 CST 2015, time=2015-10-13, status=1, ipAttribution=)]
    2015-10-13 lsndxfj
  3. [GetPortalCommentsPageByObjectIdResponse(id=1947302, encodeId=dc64194e3027c, content=<a href='/topic/show?id=d6bc160453b' target=_blank style='color:#2F92EE;'>#Sclerosis#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=16045, encryptionId=d6bc160453b, topicName=Sclerosis)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=33b92500139, createdName=12498b37m72暂无昵称, createdTime=Thu Jun 09 05:33:00 CST 2016, time=2016-06-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1364062, encodeId=49391364062f5, content=<a href='/topic/show?id=7c5615628ad' target=_blank style='color:#2F92EE;'>#ROS#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=15628, encryptionId=7c5615628ad, topicName=ROS)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=acc3210, createdName=lsndxfj, createdTime=Tue Oct 13 06:33:00 CST 2015, time=2015-10-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1496271, encodeId=aa1f14962e148, content=<a href='/topic/show?id=43b6e358710' target=_blank style='color:#2F92EE;'>#硬化性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73587, encryptionId=43b6e358710, topicName=硬化性)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d8119265602, createdName=Smile2683, createdTime=Tue Oct 13 06:33:00 CST 2015, time=2015-10-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1575434, encodeId=479015e5434fa, content=<a href='/topic/show?id=cd9941326bc' target=_blank style='color:#2F92EE;'>#地中海#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=41326, encryptionId=cd9941326bc, topicName=地中海)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=303116130321, createdName=wgx311, createdTime=Tue Oct 13 06:33:00 CST 2015, time=2015-10-13, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=1947302, encodeId=dc64194e3027c, content=<a href='/topic/show?id=d6bc160453b' target=_blank style='color:#2F92EE;'>#Sclerosis#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=16045, encryptionId=d6bc160453b, topicName=Sclerosis)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=33b92500139, createdName=12498b37m72暂无昵称, createdTime=Thu Jun 09 05:33:00 CST 2016, time=2016-06-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1364062, encodeId=49391364062f5, content=<a href='/topic/show?id=7c5615628ad' target=_blank style='color:#2F92EE;'>#ROS#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=15628, encryptionId=7c5615628ad, topicName=ROS)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=acc3210, createdName=lsndxfj, createdTime=Tue Oct 13 06:33:00 CST 2015, time=2015-10-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1496271, encodeId=aa1f14962e148, content=<a href='/topic/show?id=43b6e358710' target=_blank style='color:#2F92EE;'>#硬化性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73587, encryptionId=43b6e358710, topicName=硬化性)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d8119265602, createdName=Smile2683, createdTime=Tue Oct 13 06:33:00 CST 2015, time=2015-10-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1575434, encodeId=479015e5434fa, content=<a href='/topic/show?id=cd9941326bc' target=_blank style='color:#2F92EE;'>#地中海#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=41326, encryptionId=cd9941326bc, topicName=地中海)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=303116130321, createdName=wgx311, createdTime=Tue Oct 13 06:33:00 CST 2015, time=2015-10-13, status=1, ipAttribution=)]
    2015-10-13 wgx311

相关资讯

地中海饮食防治中年人心脑血管病 可与他汀相媲美

为了控制疾病风险,具有卒中或心脏病风险患者应采用地中海饮食,而不是一味的接受他汀治疗。这一观点正得到越来越多医学专家的认可。在最近发表的一篇声明中,众多专家一致呼吁患者健康饮食、积极运动、停止吸烟,这些生活干预方式与降脂药物治疗同样重要。另外包括英国卫生质量标准署(NICE)在内的医学团队应减少“药物治疗防控风险”的依赖性。参与该声明的专家认为,医生应为患者提供有关他汀治疗利弊的更多信息,并给出一

Diabetes Care:地中海饮食对糖尿病微血管并发症有益(PREDIMED研究)

地中海饮食预防研究(PREDIMED)是在初级医疗机构进行的多中心随机对照试验。9月13日及14日,这项研究中关于糖尿病微血管并发症及乳腺癌预防的研究结果分别在线发表于《糖尿病护理》(Diabetes Care)杂志及《美国医学会杂志 内科学》(JAMA Intern Med)。地中海饮食与糖尿病微血管并发症这项事后分析研究结果表明,地中海饮食+特级初榨橄榄油(Med Diet+EVOO)比低脂饮

JAMA Intern Med:地中海饮食可能降低乳腺癌发病风险(PREDIMED研究)

地中海饮食预防研究(PREDIMED)是在初级医疗机构进行的多中心随机对照试验。9月14日,这项研究中关于乳腺癌预防的研究结果在线发表于《美国医学会杂志 内科学》(JAMA Intern Med)。该研究纳入2003-2009年间存在心血管高危因素的4282名60~80岁女性,筛选出其中4152名无乳腺癌病史者。亦将其分为Med Diet+EVOO、Med Diet+Nuts或低脂饮食组。结果显示

专家观点:究竟应不应该计算卡路里热量摄入?

肥胖逐渐成为了现代社会年轻人中常见的现象,对人们的健康逐渐也形成了更大风险。有越来越多的证据指出,肥胖可能会增加心血管疾病和糖尿病等疾病的发病率。上个月底,在本站的转化医学频道上的一篇报道(原文《减肥,计算卡路里有用么?》),介绍了一篇发表在《Open Heart》上的分析文章。该文章指出,人们不要过分关注卡路里而转而应该关注选择更加健康的食物,这样可能会降低心血管疾病的发病风险。随着这篇报道

Arch Dis Child Fetal Neonatal Ed:孕期吸烟易早产

众所周知,吸烟、酗酒和毒品均会对身体健康造成打击性的损害,而良好的身体远离以上危险,还应该保持良好的饮食习惯和身体的锻炼。而饮食方面较为推崇的是地中海饮食——以蔬菜水果、鱼类、五谷杂粮、豆类和橄榄油为主的饮食风格。现也用“地中海式饮食”代指有利于健康的,简单、清淡以及富含营养的饮食。Smith LK等人进行了一项人群为基础的病例队列研究,探究生活方式因素对32+0-36+6周孕早产儿(LMPT)发

JAMA Intern Med:想减慢认知功能下降吗?那就多吃地中海饮食吧

氧化应激和血管损伤被认为部分介导了与年龄有关的认知减退,是痴呆症发展的一个强大的风险因素。流行病学研究表明,地中海饮食是一种富含抗氧化剂的保护心脏的膳食模式,它延迟了认知能力的下降,但目前临床试验的证据不足。所以该研究的目的是与对照性饮食相比,探索补充抗氧化剂丰富的食物的地中海式饮食是否影响认知功能。    该平行随机临床试验的参与者是来自西班牙巴塞罗那的447名认知